IUS Combined With VAT Predicts Anti-TNF-α Efficacy in Patients With IBD: a Prospective Study

NCT06165029 · clinicaltrials.gov ↗
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

The Third Xiangya Hospital of Central South University